1. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. (January 2018) Authors: Barkal, Amira; Weiskopf, Kipp; Kao, Kevin; Gordon, Sydney; Rosental, Benyamin; Yiu, Ying; George, Benson; Markovic, Maxim; Ring, Nan; Tsai, Jonathan; McKenna, Kelly; Ho, Po; Cheng, Robin; Chen, James; Barkal, Layla; Ring, Aaron; Weissman, Irving; Maute, Roy Journal: Nature immunology Issue: Volume 19:Number 1(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗